• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics.

作者信息

Borio Luciana L, Bright Rick A, Emanuel Ezekiel J

机构信息

Council on Foreign Relations, New York, New York.

The Rockefeller Foundation, New York, New York.

出版信息

JAMA. 2022 Jan 18;327(3):215-216. doi: 10.1001/jama.2021.24165.

DOI:10.1001/jama.2021.24165
PMID:34989782
Abstract
摘要

相似文献

1
A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics.《COVID-19医疗应对国家战略：疫苗与治疗方法》
JAMA. 2022 Jan 18;327(3):215-216. doi: 10.1001/jama.2021.24165.
2
COVID is here to stay: countries must decide how to adapt.新冠疫情将长期存在：各国必须决定如何适应。
Nature. 2022 Jan;601(7892):165. doi: 10.1038/d41586-022-00057-y.
3
Antiviral pills could change pandemic's course.抗病毒药丸可能会改变疫情的走向。
Science. 2021 Nov 12;374(6569):799-800. doi: 10.1126/science.acx9605. Epub 2021 Nov 11.
4
Why scientists are racing to develop more COVID antivirals.为什么科学家们竞相研发更多抗新冠病毒药物。
Nature. 2022 Jan;601(7894):496. doi: 10.1038/d41586-022-00112-8.
5
Treatment of COVID-19 in high-risk outpatients.高危门诊患者的新冠病毒病治疗
Med Lett Drugs Ther. 2022 Feb 7;64(1643):e1.
6
COVID-19 Therapeutics for Nonhospitalized Patients.适用于非住院患者的COVID-19治疗方法。
JAMA. 2022 Feb 15;327(7):617-618. doi: 10.1001/jama.2022.0335.
7
[Molnupiravir or nirmatrelvir-ritonavir reduce the likelihood of hospitalization and mortality in immunocompromised patients with Covid-19.].莫努匹拉韦或奈玛特韦-利托那韦可降低新冠病毒感染免疫功能低下患者的住院和死亡风险。
Recenti Prog Med. 2024 Sep;115(9):399. doi: 10.1701/4334.43179.
8
An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19.关于莫努匹韦的使用的最新实用指南，以及与具有治疗 COVID-19 的紧急使用授权的药物的比较。
Diabetes Metab Syndr. 2022 Feb;16(2):102396. doi: 10.1016/j.dsx.2022.102396. Epub 2022 Jan 13.
9
Hundreds of COVID trials could provide a deluge of new drugs.数百项新冠试验可能会带来大量新药。
Nature. 2022 Mar;603(7899):25-27. doi: 10.1038/d41586-022-00562-0.
10
Audio Interview: A New Antiviral against Covid-19.音频访谈：一种新型抗新冠病毒药物
N Engl J Med. 2022 Feb 17;386(7):e25. doi: 10.1056/NEJMe2202349.

引用本文的文献

1
Demographic disparities in access to COVID-19 clinical trial sites across the United States: a geospatial analysis.美国各地获得COVID-19临床试验地点的人口统计学差异：一项地理空间分析。
Int J Equity Health. 2025 Jan 23;24(1):26. doi: 10.1186/s12939-024-02360-8.
2
Efficacy of traditional Chinese medicine on shortening the negative conversion time of SARS-CoV-2 ribonucleic acid in patients with mild COVID-19: a retrospective cohort study.中药对缩短轻型新型冠状病毒肺炎患者严重急性呼吸综合征冠状病毒2核糖核酸转阴时间的疗效：一项回顾性队列研究
Sci One Health. 2023 Oct 31;2:100049. doi: 10.1016/j.soh.2023.100049. eCollection 2023.
3
Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial.
SAB-185 治疗非住院 COVID-19 成人患者的安全性和疗效：一项随机临床试验。
J Infect Dis. 2024 Nov 15;230(5):1177-1186. doi: 10.1093/infdis/jiae369.
4
Antiviral fibrils of self-assembled peptides with tunable compositions.具有可调组成的自组装肽的抗病毒原纤维。
Nat Commun. 2024 Feb 7;15(1):1142. doi: 10.1038/s41467-024-45193-3.
5
Nirmatrelvir plus ritonavir remains effective in vaccinated patients at risk of progression with COVID-19: A systematic review and meta-analysis.奈玛特韦/利托那韦片在有 COVID-19 进展风险的接种疫苗患者中仍然有效：系统评价和荟萃分析。
J Glob Health. 2023 Jul 21;13:06032. doi: 10.7189/jogh.13.06032.
6
Prevalence of COVID-19 vaccine acceptance among migrant and refugee groups: A systematic review and -analysis.移民和难民群体中新冠病毒疫苗接种的接受率：一项系统综述与分析
Vaccine X. 2023 Aug;14:100308. doi: 10.1016/j.jvacx.2023.100308. Epub 2023 May 6.
7
Use of sotrovimab in vaccinated versus unvaccinated COVID-19 patients in a resource-limited emergency department during the omicron surge.在奥密克戎毒株激增期间，资源有限的急诊科中，索托维单抗在接种疫苗与未接种疫苗的新冠患者中的应用。
J Am Coll Emerg Physicians Open. 2023 May 11;4(3):e12958. doi: 10.1002/emp2.12958. eCollection 2023 Jun.
8
Increases In COVID-19 Vaccination Among NYC Municipal Employees After Implementation Of Vaccination Requirements.纽约市市政雇员在实施疫苗接种要求后 COVID-19 疫苗接种率上升。
Health Aff (Millwood). 2023 Mar;42(3):357-365. doi: 10.1377/hlthaff.2022.00809.
9
Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19.SAB-185 治疗非住院 COVID-19 成人患者的 2 期安全性和抗病毒活性：一种新型多克隆抗体疗法。
J Infect Dis. 2023 Jul 14;228(2):133-142. doi: 10.1093/infdis/jiad013.
10
Rational drug repositioning for coronavirus-associated diseases using directional mapping and side-effect inference.利用定向映射和副作用推断对冠状病毒相关疾病进行合理的药物重新定位。
iScience. 2022 Nov 18;25(11):105348. doi: 10.1016/j.isci.2022.105348. Epub 2022 Oct 13.